Versant Ventures

Versant Ventures company information, Employees & Contact Information

Explore related pages

Related company profiles:

Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com.

Company Details

Employees
75
Founded
-
Address
One Sansome Street,
Phone
+1 415 801 8100
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
San Francisco, CA
Looking for a particular Versant Ventures employee's phone or email?

Versant Ventures Questions

News

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension - PR Newswire

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension PR Newswire

Light Horse Therapeutics Debuts With $62 Million Series A Financing - Business Wire

Light Horse Therapeutics Debuts With $62 Million Series A Financing Business Wire

Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis - Business Wire

Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis Business Wire

LENZ Therapeutics Debuts With $47 Million Series A Financing - LENZ Therapeutics

LENZ Therapeutics Debuts With $47 Million Series A Financing LENZ Therapeutics

SixPeaks Bio AG Debuts With $110 Million in Funding - The AI Journal

SixPeaks Bio AG Debuts With $110 Million in Funding The AI Journal

A Double Power Law model accurately forecasts COVID-19 transmission and mortality - medRxiv

A Double Power Law model accurately forecasts COVID-19 transmission and mortality medRxiv

Nexo Therapeutics Launches With $60 Million Series A Financing - citybiz

Nexo Therapeutics Launches With $60 Million Series A Financing citybiz

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing - PR Newswire

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing PR Newswire

Borealis Biosciences Appoints Christian Hordo as CEO and Expands Series A Financing - Yahoo Finance

Borealis Biosciences Appoints Christian Hordo as CEO and Expands Series A Financing Yahoo Finance

Versant Ventures Raises $950 Million Across Three Vehicles - Business Wire

Versant Ventures Raises $950 Million Across Three Vehicles Business Wire

Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration - PR Newswire

Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration PR Newswire

Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - Business Wire

Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies Business Wire

Versant Ventures Announces Acquisition of Portfolio Company Vividion Therapeutics - Business Wire

Versant Ventures Announces Acquisition of Portfolio Company Vividion Therapeutics Business Wire

Versant Ventures Announces Successful IPO by Black Diamond Therapeutics - Business Wire

Versant Ventures Announces Successful IPO by Black Diamond Therapeutics Business Wire

Versant Ventures Strengthens Global Team and Discovery Engine Infrastructure - Business Wire

Versant Ventures Strengthens Global Team and Discovery Engine Infrastructure Business Wire

Versant Ventures Launches Lycia Therapeutics with $50 Million - Business Wire

Versant Ventures Launches Lycia Therapeutics with $50 Million Business Wire

858 Therapeutics Announces $50 Million Series B Financing - Business Wire

858 Therapeutics Announces $50 Million Series B Financing Business Wire

858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting - Business Wire

858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting Business Wire

Firefly Bio Debuts With $94 Million Series A Financing - Business Wire

Firefly Bio Debuts With $94 Million Series A Financing Business Wire

Capsida Biotherapeutics Debuts with $140 Million of Capital - PR Newswire

Capsida Biotherapeutics Debuts with $140 Million of Capital PR Newswire

Stablix Therapeutics Launches with $63 Million Series A Financing - Business Wire

Stablix Therapeutics Launches with $63 Million Series A Financing Business Wire

Belharra Therapeutics Debuts With $130 Million in Funding - Business Wire

Belharra Therapeutics Debuts With $130 Million in Funding Business Wire

858 Therapeutics Launches with Proven Team and $60 Million Series A Financing - Business Wire

858 Therapeutics Launches with Proven Team and $60 Million Series A Financing Business Wire

Ventus Therapeutics Launches with $60 Million Series A - Business Wire

Ventus Therapeutics Launches with $60 Million Series A Business Wire

Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million - Business Wire

Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million Business Wire

Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform - PR Newswire

Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform PR Newswire

Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies - Business Wire

Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies Business Wire

Stablix Names Tony Kingsley CEO - Business Wire

Stablix Names Tony Kingsley CEO Business Wire

Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH - The AI Journal

Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH The AI Journal

Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical Officer - PR Newswire

Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical Officer PR Newswire

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases - PR Newswire

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases PR Newswire

Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies - PR Newswire

Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies PR Newswire

FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism - PR Newswire

FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism PR Newswire

Black Diamond Therapeutics Announces Spinout of Launchpad - GlobeNewswire

Black Diamond Therapeutics Announces Spinout of Launchpad GlobeNewswire

Top Versant Ventures Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant